Gate Neurosciences
PrivateLast Round
VC Round
Oct 5, 2022
Total Funding Raised
$15M
Company Overview
Gate Neurosciences is a biotechnology company that develops neuronal therapeutics aimed at treating central neurologic and psychiatric disorders by enhancing neuroplasticity and restoring healthy brain function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Mental Health, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate Neurosciences Comps
Public and private peers based on sector, stage, and business model.
Gate Neurosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 5, 2022 | ||||
| Convertible Debt | Nov 24, 2021 |
Gate Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioCrossroads | VC Round |
| Luson BioVentures | VC Round |
| Innoviva | VC Round, Convertible Debt |
Gate Neurosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gate Neurosciences's valuation, stock price, and market status.
